| Previous Close | 33.77 |
| Open | 33.86 |
| Bid | 33.68 x 11300 |
| Ask | 33.69 x 4200 |
| Day's Range | 33.65 - 33.99 |
| 52 Week Range | 29.83 - 37.39 |
| Volume | 6,326,137 |
| Avg. Volume | 21,496,393 |
| Market Cap | 200.94B |
| Beta | 1.06 |
| PE Ratio (TTM) | 28.34 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.28 (3.76%) |
| Ex-Dividend Date | 2017-05-10 |
| 1y Target Est | N/A |
- Market Realist•2 hours ago
Pfizer’s Profitability in 1Q17
Pfizer's gross margin for 1Q17 was 81.0%, a 0.70% rise compared to 80.3% in 1Q16.
- Market Realist•4 hours ago
Pfizer’s Geographical Performance in 1Q17
The Innovative Health segment reported a 9.0% rise in 1Q17 revenues compared to 1Q16 revenues from sales in the US markets.
- Market Realist•5 hours ago
Pfizer’s Segment Performance in 1Q17
Pfizer Innovative Health contributed $7.4 billion, or about 58.0% of Pfizer's total revenues in 1Q17.
